Search details
1.
An acute rise of plasma Na+ concentration associates with syndecan-1 shedding during hemodialysis.
Am J Physiol Renal Physiol
; 319(2): F171-F177, 2020 08 01.
Article
in English
| MEDLINE | ID: mdl-32538148
2.
Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers.
Nephrol Dial Transplant
; 35(9): 1570-1576, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-31005993
3.
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.
Diabetes Obes Metab
; 22(5): 798-806, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31912603
4.
Plasma syndecan-1 in hemodialysis patients associates with survival and lower markers of volume status.
Am J Physiol Renal Physiol
; 316(1): F121-F127, 2019 01 01.
Article
in English
| MEDLINE | ID: mdl-30379102
5.
Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.
Nephrol Dial Transplant
; 34(10): 1699-1706, 2019 10 01.
Article
in English
| MEDLINE | ID: mdl-30184238
6.
Personalized medicine in diabetic kidney disease: a novel approach to improve trial design and patient outcomes.
Curr Opin Nephrol Hypertens
; 27(6): 426-432, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30095480
7.
N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.
Diabetes Obes Metab
; 20(12): 2899-2904, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29987919
8.
A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores.
Ther Adv Endocrinol Metab
; 12: 2042018820974191, 2021.
Article
in English
| MEDLINE | ID: mdl-33613960
Results
1 -
8
de 8
1
Next >
>>